{"id":"https://openalex.org/W4404064157","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","title":"1281 A cancer immunotherapy modality based on dendritic cell reprogramming in vivo","display_name":"1281 A cancer immunotherapy modality based on dendritic cell reprogramming in vivo","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404064157","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1281"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1281","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010896251","display_name":"Ervin Ascic","orcid":"https://orcid.org/0000-0002-3839-0572","observed_orcids":["https://orcid.org/0000-0002-3839-0572","https://orcid.org/0009-0005-4071-3771"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ervin Ascic","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093291983","display_name":"Fritiof \u00c5kerstr\u00f6m","orcid":"https://orcid.org/0009-0005-4071-3771","observed_orcids":["https://orcid.org/0009-0005-4071-3771"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fritiof \u00c5kerstr\u00f6m","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113894136","display_name":"Malavika Sreekumar Nair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Malavika Sreekumar Nair","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andr\u00e9 Rosa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 Rosa","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053201277","display_name":"Ilia Kurochkin","orcid":"https://orcid.org/0000-0003-3100-0903","observed_orcids":["https://orcid.org/0000-0003-3100-0903","https://orcid.org/0000-0002-5706-8124"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ilia Kurochkin","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103228328","display_name":"Olga Zimmermannov\u00e1","orcid":"https://orcid.org/0000-0001-7885-2447","observed_orcids":["https://orcid.org/0000-0001-7885-2447","https://orcid.org/0000-0002-5706-8124"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Olga Zimmermannova","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033417820","display_name":"Xavier Catena","orcid":"https://orcid.org/0000-0001-7885-2447","observed_orcids":["https://orcid.org/0000-0001-7885-2447"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Xavier Catena","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]},{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035120857","display_name":"Nadezhda Rotankova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadezhda Rotankova","raw_affiliation_strings":["InSphero AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InSphero AG, Schlieren, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103308761","display_name":"Charlotte Veser","orcid":"https://orcid.org/0000-0002-8716-6729","observed_orcids":["https://orcid.org/0000-0002-8716-6729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charlotte Veser","raw_affiliation_strings":["InSphero AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InSphero AG, Schlieren, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039522243","display_name":"Micha\u0142 Rudnik","orcid":"https://orcid.org/0000-0002-8716-6729","observed_orcids":["https://orcid.org/0000-0002-8716-6729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michal Rudnik","raw_affiliation_strings":["InSphero AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InSphero AG, Schlieren, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103308759","display_name":"Tommaso Ballocci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Tommaso Ballocci","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103308760","display_name":"Tiffany Sch\u00e4rer","orcid":"https://orcid.org/0009-0007-8008-9939","observed_orcids":["https://orcid.org/0009-0007-8008-9939","https://orcid.org/0009-0004-3853-0020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiffany Sch\u00e4rer","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103325041","display_name":"Xiaoli Huang","orcid":"https://orcid.org/0009-0009-0005-7860","observed_orcids":["https://orcid.org/0009-0009-0005-7860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoli Huang","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084545725","display_name":"Maria de Rosa Torres","orcid":"https://orcid.org/0009-0009-0005-7860","observed_orcids":["https://orcid.org/0009-0009-0005-7860"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Maria de Rosa Torres","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Emilie Renaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilie Renaud","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101769867","display_name":"Marta Velasco Santiago","orcid":"https://orcid.org/0000-0002-3322-3513","observed_orcids":["https://orcid.org/0000-0002-3322-3513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Velasco Santiago","raw_affiliation_strings":["National Center of Cancer Immune Therapy (CCIT-DK), Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center of Cancer Immune Therapy (CCIT-DK), Herlev, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070159094","display_name":"\u00d6zcan Met","orcid":"https://orcid.org/0000-0002-3256-7592","observed_orcids":["https://orcid.org/0000-0002-3256-7592","https://orcid.org/0000-0002-1379-2647"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"\u00d6zcan Met","raw_affiliation_strings":["National Center of Cancer Immune Therapy (CCIT-DK), Herlev, Denmark","Technical University of Denmark, Kongens Lyngby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center of Cancer Immune Therapy (CCIT-DK), Herlev, Denmark","institution_ids":[]},{"raw_affiliation_string":"Technical University of Denmark, Kongens Lyngby, Denmark","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004367868","display_name":"David Askmyr","orcid":"https://orcid.org/0000-0003-1312-8524","observed_orcids":["https://orcid.org/0000-0003-1312-8524"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I4210137844","display_name":"Sk\u00e5ne University Hospital","ror":"https://ror.org/02z31g829","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210137844"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"David Askmyr","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Sk\u00e5ne University Hospital, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Sk\u00e5ne University Hospital, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I4210137844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043590900","display_name":"Malin Lindstedt","orcid":"https://orcid.org/0000-0001-9136-1087","observed_orcids":["https://orcid.org/0000-0001-9136-1087"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Malin Lindstedt","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065809036","display_name":"Lennart Greiff","orcid":"https://orcid.org/0000-0002-7004-1989","observed_orcids":["https://orcid.org/0000-0002-7004-1989"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I4210137844","display_name":"Sk\u00e5ne University Hospital","ror":"https://ror.org/02z31g829","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210137844"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lennart Greiff","raw_affiliation_strings":["Lund University, Lund, Sk\u00e5ne, Sweden","Sk\u00e5ne University Hospital, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"Sk\u00e5ne University Hospital, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I4210137844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049535364","display_name":"Laure\u2010Anne Ligeon","orcid":"https://orcid.org/0000-0002-4522-5807","observed_orcids":["https://orcid.org/0000-0002-4522-5807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laure-Anne Ligeon","raw_affiliation_strings":["InSphero AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InSphero AG, Schlieren, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047334223","display_name":"Irina Agarkova","orcid":"https://orcid.org/0000-0002-4522-5807","observed_orcids":["https://orcid.org/0000-0002-4522-5807","https://orcid.org/0000-0002-0930-8541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irina Agarkova","raw_affiliation_strings":["InSphero AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InSphero AG, Schlieren, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051043977","display_name":"Inge Marie Svane","orcid":"https://orcid.org/0000-0002-9451-6037","observed_orcids":["https://orcid.org/0000-0002-9451-6037","https://orcid.org/0000-0002-0930-8541"]},"institutions":[{"id":"https://openalex.org/I2801827564","display_name":"Herlev Hospital","ror":"https://ror.org/00wys9y90","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801827564","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Inge Marie Svane","raw_affiliation_strings":["National Center for Cancer Immune Therapy, Herlev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Cancer Immune Therapy, Herlev, Denmark","institution_ids":["https://openalex.org/I2801827564"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082399462","display_name":"Cristiana F. Pires","orcid":"https://orcid.org/0000-0003-2985-6323","observed_orcids":["https://orcid.org/0000-0003-2985-6323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristiana F Pires","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041021379","display_name":"F\u00e1bio Alexandre Rosa","orcid":"https://orcid.org/0000-0002-7714-5852","observed_orcids":["https://orcid.org/0000-0002-7714-5852","https://orcid.org/0000-0003-2985-6323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F\u00e1bio F Rosa","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011181093","display_name":"Carlos\u2010Filipe Pereira","orcid":"https://orcid.org/0000-0002-9724-1382","observed_orcids":["https://orcid.org/0000-0002-9724-1382"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I76903346","display_name":"University of Coimbra","ror":"https://ror.org/04z8k9a98","country_code":"PT","type":"education","lineage":["https://openalex.org/I76903346"]}],"countries":["PT","SE"],"is_corresponding":false,"raw_author_name":"Carlos-Filipe Pereira","raw_affiliation_strings":["Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","Lund University, Lund, Sk\u00e5ne, Sweden","University of Coimbra, Coimbra, Portugal","Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asgard Therapeutics AB, Lund, Sk\u00e5ne, Sweden","institution_ids":[]},{"raw_affiliation_string":"Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"University of Coimbra, Coimbra, Portugal","institution_ids":["https://openalex.org/I76903346"]},{"raw_affiliation_string":"Wallenberg Centre for Molecular Medicine at Lund University, Lund, Sk\u00e5ne, Sweden","institution_ids":["https://openalex.org/I187531555"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1436","last_page":"A1436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9549999833106995},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.6489999890327454},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pu-1","display_name":"PU.1","score":0.972000002861023},{"id":"https://openalex.org/keywords/irf8","display_name":"IRF8","score":1.0},{"id":"https://openalex.org/keywords/batf3","display_name":"Batf3","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-microenvironment-remodeling","display_name":"tumor microenvironment remodeling","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.671999990940094},{"id":"https://openalex.org/keywords/tertiary-lymphoid-structures","display_name":"tertiary lymphoid structures","score":0.8519999980926514},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7250000238418579},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6589999794960022},{"id":"https://openalex.org/keywords/immunological-memory","display_name":"immunological memory","score":0.796999990940094},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.6790000200271606},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.8849999904632568},{"id":"https://openalex.org/keywords/autoreactive-t-cells","display_name":"autoreactive T cells","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.8305126428604126},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6942824125289917},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6140679121017456},{"id":"https://openalex.org/C2780226545","wikidata":"https://www.wikidata.org/wiki/Q6888030","display_name":"Modality (human\u2013computer interaction)","level":2,"score":0.6014931797981262},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5979610085487366},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5929902791976929},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.49205392599105835},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4387323558330536},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33604949712753296},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33339089155197144},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3115164637565613},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.269417405128479},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23765525221824646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21653154492378235},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13510552048683167},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.11389169096946716},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06637734174728394}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.1281","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.1281","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.1281","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400528631","https://openalex.org/W4402260598","https://openalex.org/W4403520010","https://openalex.org/W4412835638","https://openalex.org/W4402022195","https://openalex.org/W7204464951","https://openalex.org/W4383504947","https://openalex.org/W4388077990","https://openalex.org/W6999580927","https://openalex.org/W4411034331"],"abstract_inverted_index":{"Background":[0],"Immunotherapy":[1],"modalities":[2,388],"have":[3,83],"revolutionized":[4],"cancer":[5,69,163],"treatment":[6],"and":[7,33,57,113,146,154,156,162,178,186,207,217,241,260,286,307,318,321,366,378,408],"depend":[8],"on":[9,390],"the":[10,55,72,108,166,196,228,234,282,289,373,380,391,416,423,429],"establishment":[11,290],"of":[12,35,48,59,75,107,168,227,237,281,291,334,386,394,422,432],"T":[13,61,211,243],"cell":[14,62,396],"responses":[15,63,126,299],"for":[16,64,88,375,382],"long-term":[17,292],"survival.":[18],"However,":[19],"generalized":[20],"success":[21],"has":[22],"been":[23,85],"hampered":[24],"by":[25,104,128,150,233],"insufficient":[26],"antigen":[27],"presentation,":[28],"an":[29,335,353],"immunosuppressive":[30,169,336],"tumor":[31,100,190,197,200,204,215,229,305],"microenvironment":[32],"exclusion":[34],"immunogenic":[36,319],"cells.":[37],"Conventional":[38],"dendritic":[39,49],"cells":[40,50,101,149,191,201,244,313],"type":[41],"1":[42],"(cDC1s)":[43],"are":[44,52],"a":[45,94,316,383],"rare":[46],"subset":[47],"that":[51,269,314,347,359],"vital":[53],"in":[54,77,102,131,136,144,159,165,174,184,188,195,221,270,311,329,350,399,413],"recruitment":[56],"activation":[58],"cytotoxic":[60,210],"effective":[65],"immunity":[66,220],"across":[67],"many":[68],"types.":[70],"Despite":[71],"unique":[73,392],"role":[74],"cDC1":[76,129,172,272,284,348],"antitumor":[78,368],"immunity,":[79],"their":[80,203],"functional":[81],"properties":[82],"not":[84],"deployed":[86],"yet":[87,355],"immunotherapy.":[89],"Methods":[90],"Here,":[91],"we":[92],"developed":[93],"gene":[95],"therapy":[96],"approach":[97],"to":[98,118,183,263,288,362],"reprogram":[99],"vivo":[103,132,175,400],"adenoviral":[105],"delivery":[106],"transcription":[109],"factors":[110],"PU.1,":[111],"IRF8":[112],"BATF3,":[114],"which":[115,338],"enable":[116],"them":[117],"present":[119],"antigens":[120],"as":[121,133,247],"cDC1.":[122,326],"We":[123,267,344],"assessed":[124],"immune":[125,139,148,276,395],"elicited":[127],"reprogramming":[130,158,173,273,309,328,349],"monotherapy":[134],"or":[135],"combination":[137],"with":[138,192,275,415],"checkpoint":[140,277],"inhibitors,":[141],"characterized":[142],"changes":[143],"tumor-infiltrating":[145],"peripheral":[147],"microscopy,":[151],"flow":[152],"cytometry":[153],"scRNA-seq":[155],"evaluated":[157],"human":[160,304,330],"xenografts":[161],"spheroids":[164,306],"presence":[167],"components.":[170],"Results":[171],"progressed":[176,332],"fast":[177],"more":[179,323],"efficient":[180],"when":[181],"compared":[182],"vitro":[185],"resulted":[187,310],"cDC1-like":[189,312],"increased":[193,297],"fidelity":[194],"microenvironment.":[198],"Reprogrammed":[199],"remodeled":[202],"microenvironment,":[205],"recruited,":[206],"expanded":[208],"polyclonal":[209],"cells,":[212],"induced":[213,235],"complete":[214],"regressions,":[216],"established":[218],"systemic":[219],"different":[222],"mouse":[223],"melanoma":[224],"models.":[225],"Remodeling":[226],"environment":[230],"was":[231,279],"accompanied":[232],"formation":[236],"tertiary":[238],"lymphoid":[239],"structures":[240],"CD4+":[242],"were":[245,261,411],"critical":[246],"antibody-mediated":[248],"depletion":[249],"abolished":[250],"anti-tumor":[251],"responses.":[252],"Survivor":[253],"mice":[254],"remained":[255],"tumor-free":[256],"upon":[257],"subcutaneous":[258],"re-challenge":[259],"resistant":[262],"metastatic":[264],"lung":[265],"colonization.":[266],"show":[268],"situ":[271,351],"synergized":[274],"blockade,":[278],"independent":[280],"endogenous":[283],"compartment":[285],"led":[287],"immunological":[293],"memory,":[294],"while":[295],"no":[296],"autoreactive":[298],"could":[300],"be":[301],"observed.":[302],"In":[303],"xenografts,":[308],"had":[315],"mature":[317],"signature":[320],"resemble":[322],"closely":[324],"natural":[325],"Importantly,":[327],"cancers":[331],"independently":[333],"environment,":[337],"usually":[339],"limits":[340],"immunotherapy":[341,357,387],"efficacy.":[342],"Conclusions":[343],"provide":[345],"proof-of-principle":[346],"represents":[352],"off-the-shelf,":[354],"personalized":[356],"modality":[358],"is":[360],"able":[361],"orchestrate":[363],"systemic,":[364],"durable,":[365],"safe":[367],"immunity.":[369],"This":[370],"study":[371],"paves":[372],"way":[374],"first-in-human":[376],"trials":[377],"lays":[379],"foundation":[381],"new":[384],"class":[385],"based":[389],"function":[393],"subsets":[397],"generated":[398],"through":[401],"cellular":[402],"reprogramming.":[403],"Ethics":[404],"Approval":[405],"Animal":[406],"care":[407],"experimental":[409],"procedures":[410],"performed":[412],"accordance":[414],"Swedish":[417,430],"federal":[418],"regulations":[419],"after":[420],"approval":[421],"ethical":[424],"permit":[425],"(Dnr.":[426],"5.8.18-13739/2023)":[427],"from":[428],"Board":[431],"Agriculture.":[433]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-11-06T00:00:00"}